The biotech company extends its Phase I trial (NCT06252220) of DA-1726 to eight weeks following encouraging early efficacy, ...

NVO's Q2 earnings beat but revenues miss estimates as Wegovy and Ozempic face U.S. setbacks and rising competition.

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion. Sales increased due to an 8.5% increase in revenue ...

Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk ...

Claire Reed bought medication online to lose weight before a vacation, but claims she was passing out and too nauseous to eat ...

Ozempic isn’t just for weight loss—studies show it could help prevent strokes. Discover what this means for you, and what ...